Dozent/in |
PD Dr. Christian P. R. Schmid |
Veranstaltungsart |
Vorlesung |
Code |
HS241130 |
Semester |
Herbstsemester 2024 |
Durchführender Fachbereich |
Wirtschaftswissenschaften |
Studienstufe |
Master |
Termin/e |
Di, 17.09.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 24.09.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 01.10.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 08.10.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 15.10.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 22.10.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 26.11.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 03.12.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 10.12.2024, 16:15 - 19:00 Uhr, 3.A05 Di, 17.12.2024, 17:15 - 18:45 Uhr, 3.A05 (Prüfung) |
Umfang |
2 Semesterwochenstunden |
Turnus |
weekly |
Inhalt |
The aim of the course is to introduce students to the economics of pharmaceutical markets. The course will provide students with an understanding of basic features of pharmaceutical markets and related policies. Among others we address the following topics: pharmaceutical innovation, pricing and price regulations, consumer demand, and the promotion of pharmaceuticals. |
Lernziele |
The students can
(i) describe the key characteristics of pharmaceutical markets and the economic problems associated with these characteristics
(ii) explain the behavior of several main actors (e.g. patients, health insurers, governments, the pharmaceutical industry, and so on)
(iii) assess the functioning of the market for pharmaceuticals using mathematical methods and models, and
(iv) describe the institutional background in Switzerland regarding the pricing, reimbursement and promotion of pharmaceuticals. |
Voraussetzungen |
Bachelor’s degree. The students are expected to have a good knowledge of microeconomics and econometrics. |
Sprache |
Englisch |
Anmeldung |
To attend the course / exercise, registration via e-learning platform OLAT is required. Registration is possible from 2 – 27 September 2024. The students themselves are responsible for checking the creditability of the course to their course of study. Direct link to OLAT course: https://lms.uzh.ch/url/RepositoryEntry/17577443408 |
Prüfung |
***IMPORTANT*** In order to acquire credits, resp. to take the examination, registration via the Uni Portal within the examination registration period is ESSENTIALLY REQUIRED. Further information on registration: www.unilu.ch/wf/pruefungen |
Abschlussform / Credits |
Written exam / 3 Credits
|
Hörer-/innen |
Ja |
Kontakt |
christian.schmid@doz.unilu.ch
c.schmid@css.ch |
Literatur |
Danzon, Patricia M. and Sean Nicholson (eds.) (2012), The Oxford Handbook of the Economics of the Biopharmaceutical Industry, Oxford University Press, New York.
Bhattacharya, Jay, Timothy Hyde and Peter Tu (2014), Health Economics, Palgrave Macmillan, New York. (Chapters 8, 12 – 14)
Scherer, Frederic M. (2000), The Pharmaceutical Industry, in: Culyer, Anthony J. and Joseph P. Newhouse (eds.), Handbook of Health Economics, Volume 1B, Elsevier North-Holland, Amsterdam.
Danzon, Patricia M. (2011), The Economics of the Biopharmaceutical Industry, in: Glied, Sherry and Peter C. Smith (eds.), The Oxford Handbook of Health Economics, Oxford University Press, New York. |